Ignite Creation Date:
2025-12-25 @ 5:12 AM
Ignite Modification Date:
2025-12-26 @ 4:17 AM
Study NCT ID:
NCT05515627
Status:
RECRUITING
Last Update Posted:
2025-10-24
First Post:
2022-08-12
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Atezolizumab for Idiopathic Pulmonary Fibrosis
Sponsor:
Cedars-Sinai Medical Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-02-15
Start Date Type:
ACTUAL
Primary Completion Date:
2026-10-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-04-30
Completion Date Type:
ESTIMATED
First Submit Date:
2022-08-12
First Submit QC Date:
None
Study First Post Date:
2022-08-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-10-22
Last Update Post Date:
2025-10-24
Last Update Post Date Type:
ESTIMATED